Do I buy groceries or pay the electric bill? Should I pawn some of my belongings to afford my prescription? My child is sick, so I will have to miss work to take care of him. Those are just a few of the difficult choices that OU-Tulsa health professional students confronted during the Community Access to Resources Experience.

Patients with ultra-high-risk multiple myeloma, an aggressive form of blood cancer, often respond poorly to standard treatments, including bone marrow transplant. A University of Oklahoma physician-researcher recently received $2.9 million in funding from the National Cancer Institute to study whether RedHill Biopharma’s drug opaganib, given after CAR T-cell therapy, can help the immune cells fight cancer more effectively.

A protein called Miro1 found at elevated levels in the skeletal muscle of people with type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications. Researchers found that removing Miro1 restored the muscles’ response to insulin in preclinical models, while exercise reduced the protein’s levels in people with type 2 diabetes.

Nearly one in three Native Americans live with chronic pain, more than any other segment of the U.S. population. But providing in-person relief has long been complicated by financial and geographic barriers. A University of Oklahoma mHealth initiative seeks to reduce this pain imbalance.

One in eight Oklahomans has type 2 diabetes, and an estimated one-third of the state’s adult population has undiagnosed prediabetes. University of Oklahoma researchers are developing a digital outreach program to help people understand their risk and connect with resources to help prevent the disease.